Abstract
The eukaryotic Glucose Induced Degradation/C-Terminal to LisH (GID/CTLH) complex is a highly conserved E3 ubiquitin ligase involved in a broad range of biological processes. However, a role of this complex in host anti-microbial defenses has not been described. We exploited Mycobacterium tuberculosis (Mtb) induced cytotoxicity in macrophages in a FACS based CRISPR genetic screen to identify host determinants of intracellular Mtb growth restriction. Our screen identified 5 (GID8, YPEL5, WDR26, UBE2H, MAEA) of the 12 predicted members of the GID/CTLH complex as determinants of intracellular growth of both Mtb and Salmonella serovar Typhimurium. We show that the anti-microbial properties of the GID/CTLH complex knockout macrophages are mediated by enhanced GABAergic signaling, activated AMPK, increased autophagic flux and resistance to Mtb induced necrotic cell death. Meanwhile, Mtb isolated from GID/CTLH knockout macrophages are nutritionally starved and oxidatively stressed. Our study identifies the GID/CTLH complex activity as broadly suppressive of host anti-microbial responses against intracellular bacterial infections.
Similar content being viewed by others
Introduction
Mycobacterium tuberculosis (Mtb) is an intracellular pathogen that causes tuberculosis (TB), the leading cause of global mortality due to a single infectious disease1. At the onset of infection, Mtb is inhaled into the airways and phagocytosed by resident alveolar macrophages. This initial interaction triggers the recruitment of monocyte-derived macrophages, which gradually become the more abundant host macrophage population as the infection becomes more established. It is estimated that only 5–10% of Mtb-infected individuals will progress to active TB disease1. Whether the non-progressors remain latently infected, or progress to clear the infection is a subject of ongoing debate2. Mtb has evolved to survive and grow within the macrophage through the subversion of the anti-microbial properties of the phagocyte. In brief, the bacterium blocks normal phagosomal acidification and phagosome/lysosome fusion3,4,5,6. Inside the macrophage, the bacterium also relies on access to host fatty acids and cholesterol to fuel its biosynthetic demands7. The outcome of this interplay is strongly influenced by both the macrophage lineages involved and the development of an acquired immune response. It is now known that lung macrophages comprise two separate lineages; tissue-resident alveolar macrophages that are fetal stem cell-derived and populate the lung during embryogenesis, and interstitial macrophages that are derived from blood monocytes and are recruited to the lung upon insult or infection8,9. While resident alveolar macrophages are more permissive to Mtb growth, recruited interstitial macrophages are innately more hostile to the intracellular bacteria10. Eventually, Mtb parasitization of the macrophage usually ends in the death of the infected phagocyte. However, the route to cell death also plays a major role in bacterial survival. If the infected macrophage undergoes apoptosis, Mtb will likely be killed, either in the apoptotic body or as a result of efferocytosis11,12. In contrast, macrophage death via necrosis supports Mtb growth and aids in bacterial spread13,14. One of the most significant determinants of Mtb fate inside macrophages is its ability to perforate the phagosome by an ESX-1 type VII secretion system15. Phagosomal damage releases Mtb effectors into the host cytosol that suppress apoptosis and drive necrosis13,16. Through the action of ESX-1, Mtb also inhibits macrophage anti-microbial defenses such as autophagy and inflammasome-mediated production of interleukin-1β (IL-1β)17,18.
The route to macrophage cell death is clearly important to Mtb’s success as a pathogen. Two groups have conducted genome-wide CRISPR/Cas9 screens targeting Mtb-induced macrophage cell death pathways. Zhang and colleagues screened RAW264.7 cells and identified multiple genes in the type 1 interferon signaling pathway that, when disrupted, conferred protection against Mtb-induced cell death19. Similarly, Lai et al.20 performed a whole genome screen on THP1 cells infected with M. bovis BCG and also identified hits in the type 1 interferon pathway as having protective effects on infected cells. Both of these screens used the diminished death of infected cells to select for genes that, when deleted, provided the cells with some degree of protection. In this study, we used a similar CRISPR screening approach but emphasized a different selection pressure. We hypothesized that improved cell survival could also be a result of mutations that restrict bacterial growth with the potential to identify novel host pathways of bacterial control. We performed a genome-wide CRISPR/Cas9 screen on primary Hoxb8 conditionally immortalized murine bone marrow macrophages and identified the mammalian GID/CTLH complex as a strong determinant of intracellular growth of Mtb in macrophages. We show that knockout of individual components of the GID/CTLH complex is strongly restrictive to the intracellular growth of Mtb and S. Typhimurium. Mechanistically, knockout of the GID/CTLH complex promotes anti-microbial responses in macrophages through an enhanced autophagic response, increased metabolic resilience, and resistance to cell death. GID/CTLH knockout macrophages are also anti-inflammatory and, at the same time, restrict intracellular Mtb access to essential nutrients. Our work demonstrates that the GID/CTLH complex activity broadly suppresses the macrophage’s anti-microbial responses and, therefore, represents a tractable target for host-directed therapies (HDTs) in TB control strategies.
Results
FACS-based macrophage survival CRISPR screen to identify intracellular determinants of Mtb replication
Infection of macrophages with virulent Mtb strains induces necrotic cell death13,14,21, a virulence mechanism that enables the bacteria to escape the phagosome and spread. To identify genes that contribute to improved macrophage survival after Mtb infection, we developed a flow cytometry-activated sorting (FACS)-based CRISPR screen in murine macrophages derived from estradiol responsive Hoxb8 Cas9+ conditionally immortalized myeloid precursors22 using cytotoxicity as a selection outcome, anticipating that restriction of Mtb growth would enhance cell survival. We first optimized Mtb cytotoxicity in Hoxb8 bone marrow-derived macrophages (BMDMhs) at different multiplicity of infections (MOIs). Infection of BMDMhs with the virulent Mtb Erdman strain induced ~50% macrophage cytotoxicity at MOI 1 and >75% cytotoxicity at MOI 3 after 4 days of infection, as measured by the lactate dehydrogenase (LDH) release assay (Fig. 1A). Similar levels of cytotoxicity were evident when we analyzed the infected macrophages by flow cytometry after staining with live dead viability dye (Fig. S1A). As further evidence of bacteria release from dying macrophages, an MOI-dependent increase in Mtb colony forming units (CFUs) was observed in supernatants from the infected macrophage cultures (Fig. 1B). We, therefore, chose a 4-day infection with the Mtb Erdman strain at MOI 1 as a selection pressure for our CRISPR screen as it resulted in sufficient proportions of surviving macrophages (Fig. S1A) which can be flow-sorted for downstream library preparation and sequencing. We then transduced Hoxb8 Cas9+ myeloid progenitors with the Brie knockout lentiviral single guide RNA (sgRNA) library23 that targets ~19,674 mouse protein-coding genes with four sgRNAs/gene. BMDMhs knockout libraries were differentiated from the Hoxb8 Cas9+ myeloid progenitor library (Fig. S1B) and infected with the Mtb Erdman strain at MOI 1 for 4 days. Surviving macrophages based on live dead staining were flow sorted and sequenced to identify candidate genes (Fig. 1C). We carried out the screen in three independent replicates and identified hits by comparing sgRNA read counts in the sample groups to the input unperturbed BMDMh library using the MAGeCK-VISPR pipeline (Fig. S2)24.
A Mycobacterium tuberculosis (Mtb) induced cytotoxicity in Hoxb8 bone marrow-derived macrophages (BMDMhs) at the indicated multiplicity of infections (MOI) 4 days post infection. Cytotoxicity was quantified by measuring the activity of released lactate dehydrogenase (LDH) in cell supernatants as compared to 100% LDH activity in detergent-lysed cells; n = 4 biological replicates. **P < 0.01; ***P < 0.001, one-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. B A further quantification of Mtb induced cytotoxicity in macrophages at indicated MOIs by plating colony forming units (CFUs) in cell supernatants from experimental conditions as in (A); n = 5 biological replicates. **P < 0.01; ***P < 0.001, one-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. C Schematic workflow for performing CRISPR screen to identify host determinants of Mtb restriction in macrophages. Part of this graphic was created in BioRender. Lee, B. (2024) BioRender.com/t32i914. D Volcano plot showing hits from the screen. For each gene (represented by dots), enrichment or depletion is shown in the x axis as log2 fold change while the y axis shows the corresponding −log10 p value. Significantly enriched and depleted hits are shown in red and blue colors, respectively, while unchanged hits are in gray. For significant hits, an adjusted p value of <0.05 was used as a cutoff. Screens were carried out in three independent replicates. Source data are provided as a Source Data file.
We identified 259 genes whose knockout modulated BMDMhs responses to Mtb infection based on a false discovery rate of <0.05 (Fig. 1D, Supplementary Data 1). 104 genes were significantly enriched (conferred relative protection to Mtb-induced cytotoxicity), while 155 genes were significantly depleted. The highest-scoring protective hits belonged to the TOR signaling pathway (Fig. 1D, Supplementary Data 1, 2), which has already been implicated in macrophage control of Mtb25. All the enriched 10 genes in the TOR pathway (RRAGC, LAMTOR1, RRAGA, TSC1, FLCN, TSC2, LAMTOR4, LAMTOR3, TBC1D7, RPS6KA1) are part of the mTOR signaling cascade which plays a crucial role in mammalian cell growth and nutrient signaling26. These hits are consistent with the literature that mTOR inhibition is known to activate autophagy, a host response that restricts intracellular Mtb growth in macrophages27. Our hits also included a number of genes and pathways that could negatively impact Mtb growth (Fig. 1D, Supplementary Data 2), such as the mitochondrial complex 1 (NUBPL, TMEM126B, NDUFAF4, NDUFS8, ACAD9, NDUFB9, NDUFC1), iron-sulfur cluster binding, protein dephosphorylation, regulation of GTPases activity and lysosomal functions. Mitochondrial complex 1 is a target of metformin, a promising HDT against Mtb28 while disruption of iron homeostasis in macrophages by knockout of the iron–sulfur clusters could be restrictive to Mtb growth by limiting the bacteria’s access to iron29. We also identified 5 of the 12 predicted members of the highly conserved mammalian multi-subunit GID/CTLH complex30,31 (MAEA, WDR26, UBE2H, YPEL5, GID8) (Fig. 1D, Supplementary Data 1) as potential determinants of macrophage resistance to Mtb driven cell death. Interestingly, 2 of these hits (WDR26, YPEL5) were previously identified in a related CRISPR screen in THP1 macrophages using M. bovis BCG20.
Knockout of the GID/CTLH complex in macrophages results in strong intracellular bacteria growth restriction and confers high-level resistance to Mtb-induced cell cytotoxicity
The GID/CTLH complex was first identified in yeast as a multi-subunit E3 ligase that targets surplus gluconeogenic enzymes for proteasomal degradation when glucose-starved cells are re-supplied with the substrate32,33. In mammals, the complex appears to fulfill other biological functions like cell proliferation and survival, cell migration and adhesion, erythropoiesis, and neurodegenerative diseases34. In immunity, some members of the complex (RANBP9) have been implicated in antigen processing, efferocytosis, and anti-inflammatory activities35,36. We generated de novo knockouts in Hoxb8 Cas9+ myeloid progenitors for the five GID/CTLH hits identified in our screen (MAEA, WDR26, UBE2H, YPEL5, GID8), which represent ~50% of the predicted functional members of the complex in humans and mice30. We targeted each gene with 2 sgRNAs and were able to achieve >85% knockout efficiencies (Supplementary Data 3) as analyzed by the Inference of CRISPR Edits (ICE) tool37. Similar levels of protein knockout were also confirmed by western blot analysis for all five genes in BMDMhs differentiated from the Hoxb8 Cas9+ mutants (Fig. S3). We then infected the GID/CTLH knockout BMDMhs (GID8−/−, YPEL5−/−, WDR26−/−, UBE2H−/−, MAEA−/−) differentiated from the Hoxb8 Cas9+ mutants with the Mtb Erdman strain at MOI 0.4 for 4 days to determine the intracellular growth replication rates of Mtb in these macrophages. An MOI of 0.4 was chosen to minimize macrophage cell death on the day of plating CFUs in accordance with prior optimizations (Fig. 1B, S1A). A strong Mtb growth restriction was observed in all the five GID/CTLH mutants as compared to macrophages transduced with a non-targeting scramble sgRNA control (Fig. 2A). The growth restriction phenotypes were not due to differences in bacteria uptake or phagocytosis defects as there were no significant differences when we plated CFUs 3 hours post infection (Fig. 2A). Similar intracellular growth restriction phenotypes were observed when we infected selected mutants (MAEA−/−, GID8−/−, WDR26−/−) with the Mtb Erdman-Lux reporter strain and monitored bacterial growth by luciferase expression (Fig. 2B).
A Wild-type (scramble) or indicated GID/CTLH knockout BMDMhs were infected with Mtb Erdman strain at MOI 0.4. CFUs were plated on day 0 (3 hours post infection) and on Day 4 to determine intracellular Mtb replication rates; n = 6 biological replicates. ****P < 0.001, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. B Quantification of Mtb replication in scramble or GID8−/−, MAEA−/−, and WDR26−/− BMDMhs using the Mtb Erdman-Lux strain. BMDMhs were infected at MOI 0.5, following which luciferase measurements were taken on the indicated days; n = 4 biological replicates. **P < 0.01; ***P < 0.001; ****P < 0.0001, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. C Microscopy micrographs of scramble or GID8−/−, MAEA−/−, and WDR26−/− BMDMhs infected with Mtb Erdman strain at MOI 1 taken on day 4 and 5 post-infection. Source data are provided as a Source Data file.
We also analyzed the growth restriction phenotypes of the GID/CTLH knockout BMDMhs using another intracellular bacterium, Salmonella enterica serovar Typhimurium (S. Typhimurium), in the gentamicin protection assay38. MAEA−/− and GID8−/− knockout BMDMhs were infected with the wild-type S. Typhimurium ATCC 14028s strain at MOI 10, and CFUs were plated 4 and 18 hours post infection. Again, we observed a strong intracellular growth restriction of S. Typhimurium in these mutant macrophages, compared to scramble sgRNAs (Fig. S4A). The growth restriction phenotypes were also not due to bacterial uptake differences as similar bacteria numbers were evident in scramble and mutant macrophages infected with the isogenic BFP-expressing S. Typhimurium strain, phoN::BFP39 for 1-hour, as analyzed by confocal microscopy (Fig. S4B, C). To confirm that intracellular bacterial growth restriction phenotypes of GID/CTLH knockout in macrophages were conserved in human cells, we generated GID8 and MAEA knockouts in primary human monocyte-derived macrophages (hMDMs) by directly electroporating CRISPR ribonucleoproteins (CRISPR RNPs) in monocytes40. We targeted each gene with at least 2 sgRNAs and were able to achieve 50–70% knockout efficiencies with some sgRNAs, specifically sgRNA 2 for hGID8−/− and sgRNA 1 for hMAEA−/− (Fig. S5A, Supplementary Data 3). More importantly, we observed Mtb growth restriction levels that were dependent on the degree of protein knockout in these hMDM mutants by both CFUs and luciferase readouts (Fig. S5B, C). These data illustrated the functional conservation of the GID/CTLH complex in mediating intracellular growth restriction of bacteria in both mice and humans.
To assess GID/CTLH knockout BMDMhs ability to resist Mtb-induced cell death, which was a key feature of our CRISPR screening strategy, we analyzed the mutant macrophages cell death kinetics upon infection with the Mtb Erdman strain at MOI 1 by microscopy 4- and 5-days post infection. Mtb infection induced macrophage death that resulted in about half of the cells appearing necrotic by day 4 in scrambled sgRNA macrophages (Fig. 2C), which is consistent with LDH and flow cytometry-based quantifications (Figs. 1A and S1A). Almost all the cells in the scramble control appeared necrotic by day 5 (Fig. 2C). However, GID/CTLH knockout macrophages were highly resistant to cell death with 100% survival rates on days 4 and 5. Together, these data suggested that the knockout of the GID/CTLH complex does not just restrict the intracellular growth of Mtb in macrophages but also inhibits necrotic cell death programs triggered by the bacteria.
We investigated whether knockout of other members of the GID/CTLH complex that were not identified in the primary screen also impacted Mtb growth in BMDMhs by generating RANBP9−/− and MKLN1−/− knockouts (Fig. S6A, Supplementary Data 3) and assessing bacterial growth upon infection with the Mtb Erdman-Lux reporter strain at MOI 0.5. We observed significant Mtb growth restriction in RANBP9−/− and MKLN1−/− knockout BMDMhs 4 days post-infection when compared to scramble sgRNA (Fig. S6B). RANBP9−/− and MKLN1−/− BMDMhs also displayed increased resistance to Mtb induced cell death when infected with the Mtb wild-type Erdman strain at MOI 1 for 4 days (Fig. S6C). The levels of Mtb growth restriction and resistance to cell death in RANBP9−/− and MKLN1−/− BMDMhs were lower than the GID/CTLH members identified in the screen (Fig. 2). The design of the screen clearly favored those members of the complex which, upon knockout, resulted in strongest anti-bacterial phenotypes.
Mtb-infected GID/CTLH knockout macrophages are metabolically resilient and more glycolytically active
In yeast, the GID/CTLH complex is directly involved in glucose metabolism by regulating gluconeogenesis32. Even though some studies have shown that the complex is dispensable in the regulation of carbohydrate metabolism in human cells30, others have identified glycolytic enzymes L‐lactate dehydrogenase A chain (LDHA) and pyruvate kinase M1/2 (PKM) as direct targets of GID/CTLH ubiquitination41. In fact, depletion of the GID/CTLH complex member RMND5A reduces polyubiquitination of LDHA and PKM and renders the cells more glycolytic41. Moreover, the GID/CTLH complex (member RMND5A) appears to regulate cell energy homeostasis by negatively modulating the activity of the AMP-activated protein kinase (AMPK)42. We therefore profiled the metabolic state of a selected GID/CTLH knockout BMDMhs (GID8−/−, MAEA−/− and WDR26−/−) in uninfected or Mtb infected conditions. We chose to characterize these 3 mutants further because, amongst the GID/CTLH complex members, GID8 or TWA1 is a scaffold that holds the complex together, MAEA forms part of the catalytic core30, and WDR26 was identified in a previous related screen20 and is also predicted to be central to the core structure of the complex30. We first checked the relative mRNA expression of the glycolytic enzyme hexokinase 2 (Hk2) and the gluconeogenic enzyme fructose-1,6-bisphosphatase 1 (FBP1) in these GID/CTLH knockout BMDMhs. We observed a significant increase in mRNA expression of HK2 in uninfected GID/CTLH knockout BMDMhs as compared to scramble (Fig. S7A). Mtb infection maintained a higher expression of HK2 in GID/CTLH knockout BMDMhs 4 hours post infection as compared to scramble, but these responses resolved after 24 hours of infection (Fig. S7A). This is consistent with a biphasic metabolic profile of macrophage responses to Mtb infection, which is characterized by an early upregulation of glycolytic genes in the first 4–8 hours of infection that diminishes 24–48 hours later43. We did not, however, observe any differences in FBP1 expression in uninfected or Mtb infected GID/CTLH knockout BMDMhs (Fig. S7A). These results suggest that GID/CTLH knockout in BMDMhs does not impact gluconeogenesis (at least at the transcript level) but programs the cells to a more glycolytic state, which is consistent with previous observations41.
To further confirm these phenotypes, we analyzed the metabolic status of GID/CTLH knockout BMDMhs by Seahorse extracellular flux analyses using the Agilent Mito and Glycolysis Stress Test kits. Compared to scramble sgRNA, uninfected GID/CTLH knockout BMDMhs displayed increased basal oxygen consumption rates (OCRs) and reduced spare respiratory capacity (SRC) (Fig. S7B, C) which suggested impacted mitochondrial activities and oxidative phosphorylation as a consequence of GID/CTLH knockout. In agreement with our qPCR data (Fig. S7A), we also observed increased glycolytic flux in uninfected GID/CTLH knockout BMDMhs as evidenced by high basal extracellular acidification rates (ECAR) and spare glycolytic capacity (SGC) (Fig. S7D). Under basal conditions, Mtb infection of wild type macrophages increases glycolytic rates that are required to control bacterial replication44 while at the same time decelerates mitochondrial respiration45. Indeed, when we infected scramble macrophages with Mtb for 24 hours, SRC rates collapsed to almost baseline levels (Fig. 3A, B) compared to uninfected cells (Fig. S7B, C). However, Mtb infected GID/CTLH knockout macrophages were more resilient as they maintained significantly higher basal OCRs and SRCs as compared to scramble sgRNA (Figs. 3A, B, S7C). Glycolytic rates in Mtb infected GID/CTLH knockout BMDMhs were also significantly higher as compared to scramble sgRNA (Fig. 3C, D) albeit at an even higher rate than the uninfected (Fig. S7D). Together, our qPCR and extracellular flux analysis data demonstrated that knockout of the GID/CTLH complex in macrophages impairs mitochondrial respiration and proportionally increases flux through glycolysis. However, GID/CTLH knockout BMDMhs are able to withstand an Mtb-induced bioenergetic shutdown45 despite displaying reduced spare mitochondrial capacity in uninfected conditions.
A Flux analyses of scramble or GID8−/−, MAEA−/− and WDR26−/− BMDMhs infected with Mtb Erdman strain at MOI 1 24 hours post infection. Oxygen consumption rates (OCR) were measured using the Cell Mito Stress Test Kit (Agilent). Oligo, oligomycin; FCCP, fluoro-carbonyl cyanide phenylhydrazone; Rot/A, rotenone and antimycin A. B Comparison of basal respiration and spare respiratory capacity (SRC) from (A). SRC was calculated by subtracting the normalized maximal OCR from basal OCR; n = 3 biological replicates (two technical replicates per repeat). ****P < 0.0001, one-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. C Extracellular acidification rates (ECARs) of scramble or GID8−/−, MAEA−/− and WDR26−/− BMDMhs infected with Mtb as in (A). ECARs were measured using the Agilent Seahorse Glycolysis Stress Test kit. 2DG, 2-Deoxy-D-glucose. D Comparison of basal glycolysis and spare glycolytic capacity (SGC) in the indicated BMDMh knockouts. SGC was calculated as SRC above. n = 3 biological replicates (two technical replicates per repeat). **P < 0.01; ****P < 0.0001, one-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. E Western blot analysis of AMPK phosphorylation in scramble or GID8−/−, MAEA−/−, and WDR26−/− BMDMhs uninfected or infected with Mtb at MOI 4. F Quantification of relative expression of p-AMPK in (E) and in Fig. S8A, B normalized to β-actin; n = 3 biological replicates. *P < 0.05; **P < 0.01, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. G p-AMPK/AMPK ratios of relative expressions in (E) and in Fig. S8A, B as normalized to β-actin; n = 3 biological replicates. ***P < 0.001; ****P < 0.0001, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. Source data are provided as a Source Data file.
Our metabolic analyses also pointed to a state of energy stress in GID/CTLH knockout BMDMhs, which could be regulated, in part, by AMPK, a master regulator of cell energy homeostasis46. Given that AMPK can be modulated (negatively) by the GID/CTLH complex42, we also checked AMPK activity in uninfected and Mtb-infected GID/CTLH knockout macrophages by monitoring the levels of total and activated (phosphorylated) AMPK in western blot analyses. Both uninfected and Mtb infected GID/CTLH knockout macrophages displayed reduced expression of total AMPK (Figs. 3E and S8A–C), which could possibly explain reduced SRC rates of these mutants at least in uninfected states (Fig. S7B). We, however, observed increased AMPK phosphorylation in both uninfected and Mtb-infected GID/CTLH knockout macrophages (Figs. 3E, F and S8A, B), and the P-AMPK/AMPK ratios were significantly higher in the mutants (Fig. 3G).
Dual RNA-sequencing identifies GABAergic signaling and autophagy as major host determinants of Mtb restriction in GID/CTLH knockout BMDMhs
To further identify effectors that mediate Mtb growth restriction in GID/CTLH knockout BMDMhs, we performed dual RNA-sequencing (dual RNA-seq) of Mtb-infected knockout macrophages to capture both host and bacterial transcriptomes47. Scramble sgRNAs or GID/CTLH knockout BMDMhs (GID8−/−, MAEA−/−, WDR26−/−) were infected with the Mtb smyc’::mCherry strain for 4 days. On day 4, we flow-sorted infected macrophages based on mCherry positivity and extracted RNA for dual RNA-seq47. Principal component analysis (PCA) of the macrophage transcriptomes revealed unique clustering of GID8−/−, MAEA−/− and WDR26−/− BMDMhs which, despite being slightly distant from each other, clustered close together in the first principal component as compared to scramble sgRNA (Fig. 4A). Using an adjusted p value of <0.05 and an absolute log2 fold change of > 0.5, we identified 1911 upregulated and 918 downregulated genes in GID8−/− macrophages, 2106 upregulated and 940 downregulated genes in MAEA−/− macrophages and 2890 upregulated and 1845 downregulated genes in WDR26−/− macrophages (Supplementary Data 4). Due to the similar separation of GID8−/−, MAEA−/− and WDR26−/− in our PCA analysis (Fig. 4A), we generated a Venn diagram to identify differentially expressed (DE) genes in common between the three mutant macrophage populations. Indeed, the majority of DE genes (1267 upregulated, 421 downregulated) were present in the GID8−/−, MAEA−/− and WDR26−/− Mtb infected BMDMhs (Fig. 4B, C, Supplementary Data 4). Among the highly upregulated genes in the commonly DE gene set were those involved in macrophage effector functions that are known to control Mtb replication, such as the NADPH oxidase (NOX3) and autophagy (ATG9B, TRIM2, TRIM7, and TRIM16) (Supplementary Data 4). Ferroportin 1 (SLC40A1), the only known membrane protein to transport iron out of the cells48, was also among the most significantly upregulated genes in GID8−/−, MAEA−/− and WDR26−/− Mtb infected BMDMhs (Supplementary Data 4). This suggested that GID/CTLH knockout in BMDMhs could restrict Mtb growth by nutrient (iron) limitation, enhancing autophagy and increasing the production of reactive oxygen species (ROS). Given that the role of the GID/CTLH complex in macrophage anti-microbial functions is mostly unknown, we used our RNA-seq results to check the expression status (at transcript level) of the 12 GID/CTLH members, at least in wild-type (scramble) Mtb infected macrophages. We detected transcripts for all 12 members of the GID/CTLH complex, which suggests active expression of the entire complex in myeloid cells (Fig. S9A).
A Principal component analysis (PCA) of scramble or GID8−/−, MAEA−/− and WDR26−/− knockout host (BMDMhs) transcriptomes infected with the Mtb smyc’::mCherry strain at MOI 0.5 4 days post infection. B, C Venn diagrams of upregulated and downregulated gene sets (Supplementary Data 4) in GID8−/−, MAEA−/− and WDR26−/− BMDMhs as compared to scramble showing overlapping genes. Differentially expressed genes cutoff; abs (log2 fold change) >0.5, adjusted p value < 0.05. D Tree plot of top 50 enriched gene ontology terms (biological process) amongst the 1267 commonly upregulated genes in GID8−/−, MAEA−/−, and WDR26−/− BMDMhs.
To gain more insights into biological pathways that could mediate Mtb growth restriction in GID/CTLH knockout macrophages, we performed pathway enrichment analysis49 of the GID8−/−, MAEA−/− and WDR26−/− commonly DE genes (Supplementary Data 4). In the upregulated gene set, we identified 60 biological processes (BP), 30 cellular components (CC), and 27 molecular functions (MF), which were enriched based on an adjusted p value of <0.05 (Fig. 4D, Supplementary Data 5). Amongst the commonly downregulated DE genes, 332 BP, 16 CC, and 44 MF were enriched (Fig. S9B, Supplementary Data 5). Of the top enriched BPs in the commonly upregulated genes (Fig. 4D), the most enriched pathways included those involved in Ca2+ and G protein receptor signaling, effector processes that are known to play important roles in macrophage responses against Mtb50,51. Of note, γ-Aminobutyric acid (GABA) and neurotransmitter transport were, similarly, amongst the most enriched pathways in the GID/CTLH knockout upregulated genes (Fig. 4D, Supplementary Data 5). Within the GID/CTLH complex, only one member (Muskelin, MKLN1) has been shown to be involved in GABA receptor trafficking and internalization52. We, however, identified six genes in the GABAergic signaling pathway (GABBR1, GABRB2, GABARAPL1, SLC32A1, SLC6A13, SLC6A12) which were upregulated in all the three Mtb infected GID/CTLH knockout mutants; GID8−/−, MAEA−/− and WDR26−/− (Supplementary Data 4 and 5). In fact, GABBR1 and GABRB2 were amongst the most significantly upregulated genes in the GID/CTLH knockout macrophages with up to 350-fold upregulation as compared to scramble sgRNA (Supplementary Data 4). GABAergic signaling has recently been linked to intracellular macrophage control of Mtb and S. Typhimurium. Treatment of macrophages with GABA or GABAergic drugs enhances the anti-microbial properties of macrophages against intracellular bacterial infections by promoting phagosome maturation and autophagy53. Moreover, the apparent GABAergic protective responses in BMDM macrophages were driven, in significant part, by an increase in Ca2+ signaling53. Taken together, our pathway enrichment data suggested that GID/CTLH knockout in BMDMhs increases GABA and Ca2+ signaling, which may, similarly, promote macrophage control of Mtb by promoting autophagy53. A further consequence of GABA treatment in Mtb infected BMDMs and in infected mice lungs in vivo was the inhibition of pro-inflammatory markers such as Tnf and IL-653. Similarly, pro-inflammatory pathways were the most significantly enriched pathways in our GID/CTLH commonly downregulated genes (Fig. S9B, Supplementary Data 5). These included pathways involved in IL-1β production, antigen presentation, toll receptor signaling, and cellular responses to Tnf. Our further analysis of the RNA-seq data did indeed show significant downregulation of IL-1β and Tnf transcripts in all the GID/CTLH knockout macrophages infected with Mtb on day 4 (Fig. S9C). Consistent with the known role of the GID/CTLH complex in cell proliferation34, pathways related to DNA replication were also among the most enriched in the downregulated gene set (Fig. S9B). We also observed a significant downregulation of pathways related to cell death programs and apoptosis signaling (Supplementary Data 5) in GID/CTLH knockout BMDMhs, which would possibly explain the increased resistance of these macrophages to Mtb-induced cytotoxicity (Fig. 2C).
Nutritional stress is the main transcriptome signature of intracellular Mtb in GID/CTLH knockout BMDMhs
To assess the impact of host stressors on Mtb, we analyzed parallel transcriptomes of intracellular Mtb (Fig. 4A). Using an adjusted p value of <0.05 and an absolute log2 fold change of >0.3, we identified 168 Mtb genes (87 upregulated, 81 downregulated) in GID8−/− BMDMhs, 40 Mtb genes (13 upregulated, 27 downregulated) in MAEA−/− BMDMhs and 46 Mtb genes (22 genes upregulated, 26 downregulated) in WDR26−/− BMDMhs which were DE (Fig. 5A, Supplementary Data 6). Interestingly, clusters of upregulated Mtb genes in these GID/CTLH knockout BMDMhs were readily categorized into essential Mtb biological processes such as iron scavenging, cholesterol breakdown, fatty acid oxidation, amino acid metabolism and stress responses (Fig. 5B). Mtb utilizes Fe3+ iron specific siderophores, mycobactins and carboxymycobactins, to scavenge and acquire iron from the host for its nutritional requirements. Mtb mycobactins are organized into a cluster of Mbt (MbtA-MbtJ) and Mbt-2 (MbtK-MbtN) genes54. We identified five genes in the Mbt cluster (MbtB, MbtI, MbtD, MbtE, MbtF) which were upregulated in Mtb transcriptomes isolated from GID/CTLH knockout BMDMhs (Fig. 5B, Supplementary Data 6). A positive regulator of Mbt operonic gene expression, HupB55, was also upregulated in all the three Mtb transcriptomes isolated from GID/CTLH knockout macrophages (Fig. 5B, Supplementary Data 6). These data suggested that GID/CTLH knockout macrophages, in part, limit intracellular Mtb growth by reducing the bacteria’s access to iron. This is consistent with our host transcriptome data which showed a significant upregulation of the iron efflux transporter (SLC40A1) in GID/CTLH knockout macrophages (Supplementary Data 4). The data is also consistent with our previous findings, which have shown that iron limitation is one of the prominent stresses experienced by Mtb in vivo in lung interstitial macrophages, which are less permissive to Mtb growth47 and that similar Mtb-restrictive phenotypes can be reproduced in human macrophages using iron chelating chemical inhibitors29. Mtb nutrient limitation in GID/CTLH knockout macrophages was not limited to iron as we also observed an upregulation of genes involved in beta-oxidation of fatty acids (FadE9, FadD5, FadE22, FadE23)56, cholesterol breakdown (HsaD)57 and several members of the Mce1 operon (Mce1A, Mce1B, Mce1F, Mce1C, yrbE1A, IprK), which is required for Mtb fatty acid import58,59. Our previous work has demonstrated that limiting Mtb’s access to iron can upregulate cholesterol metabolism genes to re-balance impaired metabolic fluxes that arise due to diminished activity of iron-dependent metabolic pathways29. Even though upregulation of Mtb lipid metabolism genes in GID/CTLH knockout macrophages could, indeed, be a compensatory mechanism to iron limitation29, Mtb nutrient restriction in these macrophages appears to be more pervasive as the bacteria also upregulates genes involved in tryptophan biosynthesis pathways (TrpE, TrpA) (Fig. 5B, Supplementary Data 6). Mtb scavenges tryptophan from its host macrophage, however, upon immune activation, the macrophage turns on its tryptophan degradation pathway, and the bacteria respond by upregulation of its tryptophan biosynthetic genes60,61. GID/CTLH knockout macrophages also appear to induce other non-nutritional stresses to intracellular Mtb as evidenced by the upregulation of genes required to enhance survival at low pH in the phagosome (Rv1264)62. Mtb DNA damage and repair genes (DnaN, DnaB, gyrB, recA) (Fig. 5B) were also upregulated, which is indicative of increased oxidative stress as we have previously observed in Mtb isolated from growth-restrictive interstitial macrophages in vivo47.
Interestingly, Mtb in GID/CTLH knockout macrophages downregulated major virulence genes, including those belonging to the ESX-1 type VII secretion system (Fig. 5B). We identified 4 genes in the ESX-1 operon (espA, esxB, esxH, espF) which were significantly downregulated in Mtb isolated from GID/CTLH knockout macrophages. A further three genes (WhiB1, WhiB3, WhiB6) belonging to the WhiB-like family of transcription factors that play key roles in Mycobacteria virulence and antibiotic resistance63 were also significantly downregulated (Fig. 5B, Supplementary Data 6). Of note, WhiB6 is one of the main regulators of ESX-1 gene expression in Mtb64,65. Central to the activity of all WhiB transcription factors are highly conserved cysteine-bound iron-sulfur clusters that can act as reductive sinks to host nitric oxide or ROS produced during macrophage activation63. It has been demonstrated that disruption of iron-sulfur clusters in WhiB transcription factors either by iron limitation or excessive nitrosative stress can trigger a significant reprogramming of gene expression in Mtb66. Downregulation of Mtb WhiB genes in GID/CTLH knockout macrophages could also, therefore, be a result of iron-limiting conditions in these mutant phagocytes, which in the case of WhiB6 could trigger a feed-forward effect to downregulate downstream ESX-1 genes. As a consequence of ESX-1 downregulation, Mtb resident in GID/CTLH knockout macrophages may be attenuated and possibly trapped in phagosomes, given the role of this secretion system in Mtb virulence and phagosomal escape15. Several toxin-antitoxin (TA) genes were also downregulated in Mtb isolated from GID/CTLH knockout macrophages (Fig. 5B, Supplementary Data 6). Despite a reductive evolution in the Mtb genome, TA systems have been maintained to support Mtb replication, virulence and stress adaptation67. Reduced expression of Mtb TA genes in GID/CTLH knockout macrophages could thus be a further indication of shutdown in most bacterial virulence processes in parallel with the observed growth restriction phenotypes (Figs. 2A, B).
GID/CTLH knockout macrophages display increased GABAergic and Ca2+ signaling
We followed up on our dual RNA-seq data (Fig. 4) to experimentally validate some of the host effectors that mediate Mtb growth restriction in GID/CTLH knockout BMDMhs. We first checked the levels of GABA signaling in mutant macrophages by staining the cells for total endogenous GABA with an anti-GABA antibody. Murine BMDMs and lung macrophages express functional GABA in resting states53, and we assessed levels of GABA in uninfected scramble BMDMhs by confocal microscopy (Fig. S10A). All the three uninfected GID/CTLH knockout BMDMhs had significantly higher levels of GABA as compared to scramble sgRNA (Figs. S10A and 6B). It was previously shown that Mtb infection of mouse BMDMs in vitro and in vivo significantly decreases GABA levels53. In agreement with these findings, we observed a marked reduction of GABA expression in Mtb-infected scramble BMDMhs (Fig. 6A). In contrast, Mtb infection significantly amplified GABA levels in GID/CTLH knockout BMDMhs to even greater levels than uninfected cells (Fig. 6A, B).
A Representative confocal images of Mtb infected anti-GABA stained BMDMhs. Scramble, GID8−/−, MAEA−/− and WDR26−/− BMDMhs were infected with the Mtb Erdman hsp60::GFP strain at MOI 4 for 24 hours. Fixed and permeabilized cells were then stained with anti-GABA (red) for confocal imaging. B Quantification of mean fluorescence intensities (MFI) of GABA staining in (A) and Fig. S10A. MFI was quantified in at least 50 cells for both scramble and knockouts; n = 50 cells. *P < 0.05; ***P < 0.001; ****P < 0.0001, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. Source data are provided as a Source Data file.
Increased GABAergic signaling can positively modulate intracellular Ca2+ mobilization68. Moreover, Ca2+ signaling and transport were over-represented in GID/CTLH knockout BMDMhs commonly upregulated genes (Fig. 4D). We, therefore, checked intracellular Ca2+ mobilization in GID/CTLH knockout BMDMhs by loading the cells with a cell-permeable fluorogenic calcium-binding dye (Fluoforte®) followed by quantification of emitted fluorescence post stimulation with a Ca2+ mobilization agonist, adenosine triphosphate (ATP). Compared to scramble sgRNA BMDMhs, uninfected GID/CTLH knockout BMDMhs displayed increased intracellular calcium mobilization as evidenced by significantly higher normalized fluorescence 5 minutes after stimulation with ATP (Fig. S10B). In common with GABA signaling, Mtb infection significantly reduced Ca2+ mobilization in scramble BMDMhs but amplified the responses in GID/CTLH knockout macrophages (Fig. S10B). These functional data corroborate our host dual RNA-seq data sets, which showed a specific enrichment of GABAergic and Ca2+ signaling pathways in Mtb-infected GID/CTLH knockout macrophages (Fig. 4D, Supplementary Data 5).
GID/CTLH knockout macrophages are more autophagic and anti-inflammatory
Increased GABA signaling in macrophages enhances anti-microbial responses by promoting autophagy53. GABARAPL1, one of the upregulated GABA type A receptor in GID/CTLH knockout BMDMhs (Supplementary Data 4) is a homolog of the autophagy related protein 8 (ATG8)69. Genes involved in the autophagic process (ATG9B, TRIM2, TRIM7, and TRIM16) were also among the most significantly upregulated in Mtb infected GID/CTLH knockout BMDMhs (Supplementary Data 4). Moreover, in both uninfected and Mtb infected conditions, GID/CTLH knockout BMDMhs display significantly increased AMPK phosphorylation (Figs. 3E–G and S8A, B). AMPK activates catabolic processes like autophagy as part of the energy stress response in cell-starvation conditions46. These observations suggested that GID/CTLH knockout BMDMhs may be more autophagic as part of their anti-microbial responses. We therefore checked autophagic flux in GID/CTLH knockout BMDMhs by (1) immunoblotting to monitor the turnover of the microtubule-associated protein light chain 3 (LC3) from its LC3I to LC3II version (2) confocal imaging of anti-LC3 stained cells to quantify total LC3 puncta per individual cell and LC3 colocalizing with fluorescent Mtb. We observed significantly increased autophagic flux in Mtb infected GID/CTLH knockout BMDMhs as evidenced by high LC3I to LC3II turnover ratios when compared to scramble BMDMhs (Figs. 7A, B, and S11A, B). The magnitude of LC3I to LC3II turnover proportionally increased based on the bacterial burden at different MOIs (Figs. 7A, B and S11A, B). Some GID/CTLH knockout BMDMhs (MAEA−/−) displayed increased LC3I to LC3II turnover even in uninfected conditions (Figs. 7A, B, and S11A, B). Furthermore, Mtb-infected GID/CTLH knockout BMDMhs displayed significantly higher numbers of total LC3 puncta per cell as compared to scramble when we analyzed the anti-LC3 stained cells by confocal microscopy (Fig. S11C, D). More importantly, GFP expressing Mtb significantly colocalized with LC3 in GID/CTLH knockout BMDMhs (Fig. S11C, E) when compared to scramble sgRNA, which indicated increased autophagic targeting of Mtb in these mutant macrophages. Even though knockout of the GID/CTLH member, MAEA, has been shown to impair autophagy70 in hematopoietic stem cells, our data supports the contention that increased autophagy is one of the main drivers of Mtb restriction in GID/CTLH knockout macrophages.
A Western blot analysis of autophagic LC3I to LC3II turnover in uninfected and Mtb infected scramble or GID8−/−, MAEA−/−, and WDR26−/− BMDMhs at indicated MOIs. B Densitometry quantification (in %) of LC3I to LC3II turnover (LC3II/LC3I ratio) in (A) and Fig. S11A, B as normalized to β-actin; n = 3 biological replicates. *P < 0.05; **P < 0.01; ****P < 0.0001, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. C Analysis of the expression of interferon 1 beta (IFN-β) in scramble or GID8−/−, MAEA−/− and WDR26−/− Mtb infected macrophages. BMDMhs were infected at MOI 4, and RNA was extracted for qPCR at 4 and 24 hours post infection; n = 3 biological replicates. *P < 0.05; ****P < 0.0001, two-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. ELISA was carried out in culture supernatants 24 hours post infection; n = 4 biological replicates. ****P < 0.0001, one-way ANOVA alongside Dunnett’s multiple comparison test. Data are presented as mean values ± SD. Source data are provided as a Source Data file.
Mtb infected macrophages with increased GABA expression also diminish the expression of pro-inflammatory markers53. We checked the expression of pro-inflammatory markers (IL-1β and type 1 interferons (IFN-β)) in GID/CTLH knockout macrophages during the early stages of Mtb infection. We already observed a significant downregulation of pro-inflammatory markers including Tnf and IL-1β in GID/CTLH knockout macrophages in our RNA-seq data, collected 4 days post infection (Fig. S9). We concentrated our further analysis of the expression of IFN-β and IL-1β in the first 24 hours of infection. qPCR analysis showed that Mtb infection caused a significant upregulation of IFN-β mRNA in scramble macrophages 4 hours post infection, but this response diminished 24 hours post infection (Fig. 7C). In contrast, IFN-β mRNA expression was completely suppressed in GID/CTLH knockout macrophages at both time points, and this was confirmed by ELISA quantification of IFN-β in cell supernatants 24 hours post infection (Fig. 7C). mRNA levels of IL-1β significantly increased in GID/CTLH knockout macrophages during the early 4 hours of infection, but this quickly resolved after 24 hours of infection to non-significant levels (Fig. S12A). This contrasted with depleted levels of IL-1β mRNA 4 days post infection in our RNA-seq data (Fig. S9B, C). We were, however, able to confirm by ELISA that the reduction of IL-1β mRNA expression at 24 hours corresponds with significantly lower levels of released IL-1β in culture supernatants as compared to scramble sgRNA (Fig. S12A). Western blot analysis demonstrated that both the pro and mature versions of IL-1β were equally impacted (Fig. S12B), suggesting that the anti-IL-1β properties of GID/CTLH knockout could be occurring upstream of IL-1β caspase mediated processing. These data provide further evidence that GID/CTLH knockout impairs the production of pro-inflammatory markers in Mtb-infected macrophages.
Discussion
In this report, we have employed a high throughput CRISPR genetic screen in primary macrophages to identify host effectors which, upon perturbation, improve the control of intracellular replication of Mtb. In the screen, pathways known previously to interfere with Mtb growth when perturbed, such as mTOR signaling and the mitochondrial OXPHOs, were specifically enriched. However, we also identified a novel role for the mammalian GID/CTLH complex in macrophage anti-microbial properties and found that its presence and activity correlated inversely with intracellular Mtb replication.
The GID/CTLH complex is an evolutionarily conserved member of the E3 ubiquitin-proteasome system, which was initially identified in yeast as a regulator of gluconeogenesis32 but is more functionally diverse in higher eukaryotes34. With up to 12 functional members of the complex identified in mice and humans30,34, the catalytic core of the complex is formed by the 2 RING proteins MAEA and RMND5A, while GID8 (TWA1) is a predicted scaffold that holds the complex together30. The biological significance of the complex in mammals is still being investigated34. However, it is ubiquitously expressed in most mammalian cells30, which suggests its activities may have evolved to fulfill diverse functions. As we show in this study, all 12 members of the GID/CTLH complex appear to be actively transcribed in macrophages. Individual knockout of >50% of the GID/CTLH complex members in murine and human macrophages renders these phagocytes hostile to the intracellular replication of both Mtb and S. Typhimurium. It has been suggested that the GID/CTLH complex is involved in regulating cell proliferation, death, and survival pathways34. SiRNA-mediated knockdown of the GID/CTLH complex member RANBP9 made the cells more resistant to programmed cell death71,72. Indeed, knockout of the GID/CTLH complex in macrophages also rendered these phagocytes more resistant to Mtb induced necrotic cell death, a favorable host outcome, which can limit bacterial spread and virulence11,14. Moreover, GID/CTLH knockout in macrophages reprogrammed these cells to a more glycolytic state with increased activation of AMPK in line with previous observations41,42. Our results also identified additional anti-microbial responses upregulated in GID/CTLH complex knockout macrophages, such as the NADPH oxidase, autophagy, GPCR signaling, iron efflux, GABAergic signaling, and intracellular Ca2+ mobilization. GABAergic signaling has only recently been implicated in macrophage control of intracellular bacterial pathogens by promoting autophagy and inhibiting the production of pro-inflammatory cytokines53. Our results independently corroborate these findings as we observe increased GABA levels in GID/CTLH knockout BMDMhs, which is accompanied by enhanced autophagy and elevated anti-inflammatory properties. Dual RNA-seq also revealed that Mtb residing in GID/CTLH knockout macrophages displayed transcriptional signatures consistent with nutritional stress as characterized by the upregulation of iron scavenger pathways, cholesterol breakdown, amino acid metabolism, fatty acid import, and oxidation.
There is an increased interest in the incorporation of HDTs in anti-TB drug regimens as a possible means of shortening the duration of treatment28,51,73,74. In theory, HDTs have the potential to (1) enhance host immune responses (2) promote macrophage control of intracellular Mtb (3) reduce non-productive and tissue injurious inflammation to improve lung function, and (4) minimize host stresses that lead to induction of Mtb drug tolerance74. As we report, knockout of the GID/CTLH complex in macrophages induces a broad range of anti-TB responses and results in anti-inflammatory host cells, which suggests it would make a tractable target for HDTs against Mtb. Several members of this complex are upregulated in a variety of cancers, and targeting this complex for cancer therapeutics is an area of current interest34,75,76,77. As efforts continue to identify novel HDTs against TB1,51,74,78, the GID/CTLH complex offers an attractive target, and discovery efforts could benefit from the emerging therapeutic pursuit of the complex in the cancer field.
Methods
Ethics statement
The protocols used in this study have been reviewed and approved by the Institutional Biosafety Committee (protocol #16291-3) and the Institutional Animal Care and Use Committee (protocol # 2011-0086) at Cornell University.
Bacterial strains
The parent Mtb Erdman strain (ATCC 35801, PDIM positive) was used in all CFU experiments. Fluorescent Mtb reporters in the Erdman background; Mtb Erdman smyc’::mCherry and Mtb Erdman hsp60::GFP have been described previously79,80. The Mtb Erdman-Lux strain was generated by transformation with the pMV306G13+Lux plasmid81. Mtb was grown to log phase at 37 °C in MiddleBrook 7H9 broth supplemented with 10% oleic acid/albumin/dextrose/catalase (OADC Enrichment; Becton, Dickinson and Company), 0.2% glycerol, and 0.05% tyloxapol (Sigma-Aldrich). Reporter strains were maintained in the presence of an appropriate antibiotic; Mtb Erdman-Lux Mtb strain: 25μg/ml kanamycin, Mtb Erdman hsp60::GFP: 25μg/ml kanamycin and 50 μg/ml hygromycin, Mtb Erdman smyc’::mCherry: 50 μg/ml hygromycin. For Salmonella experiments, wild-type S. Typhimurium (CA32; ATCC 14028s) and the BFP expression strain S. Typhimurium CA4705 phoN::BFP39 were used. Salmonella strains were propagated at 37 °C in Luria-Bertani (LB) broth.
Mammalian cells and culture
Murine Hoxb8-Estradiol (ER) responsive Cas9+ eGFP conditionally immortalized myeloid progenitor cells were generated as previously described22. Hoxb8-ER cells were maintained in RPMI (Corning®) supplemented with 10% fetal bovine serum (FBS), 2 mM L-glutamine, 1 mM sodium pyruvate, 20 ng/ml murine GM-CSF (PeproTech), 0.5 μM β-estradiol, 10 mM HEPEs and 1% penicillin/streptomycin. To obtain BMDMhs from Hoxb8-ER myeloid progenitors, cells were rinsed twice with 1× PBS to completely remove β-estradiol and resuspended in BMDM differentiation media; DMEM (Corning®) supplemented with 10% FBS, 15% L-cell conditioned media, 2 mM L-glutamine, 1 mM sodium pyruvate, and 1% penicillin/streptomycin at 37 °C for 6–7 days. Cells were maintained at a density of ~0.5 × 106 cells/ml during differentiation. The HEK-293FT cell line was purchased from Invitrogen and cultured in DMEM supplemented with 10% FBS, 1% non-essential amino acids, 2 mM L-glutamine, 1 mM sodium pyruvate, and 1% penicillin/streptomycin. Human monocytes were commercially obtained from the University of Nebraska Medical Center Elutriation Core and differentiated to HMDMs in DMEM medium with 2 mM L-glutamine, 1 mM sodium pyruvate, 10 mM HEPES, 1% penicillin/streptomycin and 10% pooled human serum (Sera Care).
Infection of macrophages with Mtb
BMDMhs were infected with Mtb as previously described82. Briefly, log phase bacteria were pelleted, resuspended in basal uptake buffer (25 mM dextrose, 0.5% bovine serum albumin, 0.1% gelatin, 1 mM CaCl2, 0.5 mM MgCl2 in PBS) and syringed with a tuberculin syringe for at least 20 times. Bacteria were then resuspended in antibiotic free macrophage media before infection at specified MOIs.
CFU quantification of intracellular bacteria
Confluent macrophage monolayers (human and murine) were infected with Mtb at an appropriate MOI. After 3–4 hours, extracellular bacteria were removed by washing with fresh macrophage media at least three times. At indicated time points, macrophages were lysed with 0.01% SDS in water for 15 minutes and serially diluted in 0.05% Tween-80 in 1× PBS. Lysates were plated on 7H10 OADC agar plates and incubated at 37 °C for CFU counting 3–4 weeks later.
Cloning of sgRNAs, lentiviral production, and transduction
sgRNAs for CRISPR-mediated gene knockouts (Supplementary Data 3) were selected from the Brie murine knockout library23 or ordered in predesigned form from IDT for human CRISPR RNP targets. For lentiviral delivery of sgRNAs, oligo pairs were annealed and cloned into the pLentiGuide-Puro (Addgene #52963). sgRNA inserts were confirmed by sequencing. To generate lentivirus particles for transduction, pLentiGuide-Puro plasmids with sgRNAs of interest were co-transfected with Invitrogen packaging plasmids (pLP1, pLP2, and pLP/VSVG) in 293FT cells using the Lipofectamine 3000 lentiviral production protocol according to manufacturer’s guidelines. To transduce Hoxb8 Cas9+ eGFP progenitors, 2.5 × 105 cells in 12-well plates were spin-infected at 1000 × g for 90 minutes at 32 °C in the presence of 10 µg/ml protamine sulfate. 48 hours post-transduction, 8 µg/ml puromycin was added and maintained for 4 days. After the 4-day selection period, puromycin-resistant cells were briefly expanded for 1–2 days and frozen for future experiments. To quantify CRISPR editing efficiencies, total genomic DNA was prepared from cell pellets using the Qiagen DNeasy Blood and Tissue kit from which genomic sites surrounding the sgRNA target sites were PCR amplified using the Invitrogen Platinum Taq polymerase. Population-level editing efficiencies were estimated using ICE37 and western blot analysis of differentiated BMDMhs.
CRISPR screen knockout library preparation
The murine Brie knockout library was obtained from Addgene (#73633)23. The library (in pLentiGuide-Puro background) contains 78,637 sgRNAs targeting 19,674 genes (four sgRNAs/gene) with an additional 1000 non-targeting sgRNA controls. The library was amplified using the Moffat’s lab CRISPR knockout library amplification protocol83. To generate lentivirus, 293FT cells were transfected as described above, scaling up tissue culture flasks depending on the amount of virus required to achieve desired library coverage. ~180 million Cas9 eGFP Hoxb8 progenitor cells were then transduced with the lentiviral library in the presence of 8 µg/ml polybrene at an MOI of ~0.3 (8 12-well plates, 2 × 106 cells/well, >700× library coverage) to ensure that only a single gene was targeted in every cell. 48 hours post-transduction, cells were selected with 8 µg/ml puromycin for 4 days and frozen in multiple aliquots of >40 million cells (>500× library coverage). Before screening, each aliquot was thawed and allowed to recover in Hoxb8 media for 3–4 days. Cells were then rinsed in 1× PBS at least 2 times before transfer into BMDM differentiation media to generate BMDMhs knockout libraries.
Mtb infection of BMDMh knockout library, antibody staining, and flow sorting
The BMDMh knockout library was infected with the Mtb Erdman strain at MOI 1 for 4 days. The screen was carried out in three independent replicates with ~200 million cells per replicate (2 T-300 flasks). On day 4, all the cells were harvested by initially pretreating cell monolayers with Accutase for 5–10 minutes at room temperature, followed by scrapping in cold 1× PBS. Harvested cells were stained with the live/dead viability dye eFlour 506 (Invitrogen; 1:1000) and the PE anti-mouse/human CD11b antibody (Biolegend; 1:500) for 30 minutes at 4 °C. Stained cells were fixed in paraformaldehyde (PFA) for >1 hour before FACS of cells in the live gate. FACS was carried out on a Sony MA900 sorter, and a minimum of 10 million cells were sorted per replicate to achieve a >150× library coverage.
DNA extraction, barcode amplification, sequencing and analysis
Genomic DNA was extracted from the sorted cells as well as the unperturbed input library at full coverage (>300× library coverage) using a modified salt precipitation protocol as described previously84. Briefly, for 3 × 107−5 × 107 frozen cell pellets (scaled down proportionally for lower cell numbers), 6 ml of NK Lysis Buffer (50 mM Tris, 50 mM EDTA, 1% SDS, pH 8) and 30 μl of 20 mg/ml Proteinase K (Qiagen) were added to the cells in a 15 ml falcon tube and incubated at 55 °C overnight to lyse the cells and de-crosslink PFA fixation. Next day, 30 μl of 10 mg/ml RNAse A diluted in NK lysis buffer was added to the lysed sample and incubated at 37 °C for 30 minutes. Samples were chilled on ice before the addition of 7.5 mM ice-cold ammonium acetate to precipitate proteins. After a brief vortex, insoluble protein fractions were pelleted by centrifugation at ≥4000 × g for 10 minutes. The supernatant was transferred to a new 15 ml falcon tube and DNA was precipitated with Isopropanol. Precipitated DNA was washed three times with 70% ethanol and airdried. Dried pellets were dissolved in sterile nuclease-free water and DNA concentration was measured on a Nanodrop 1000 (Thermo Scientific). Amplification of sgRNAs cassettes from the extracted DNA was performed using Illumina compatible primers from IDT as described previously23 with some minor modifications. PCR amplification was carried out using KAPA HIFI Hotstart PCR (Roche) with the following reaction mixture in a 50 μl volume: 10 μL 5× reaction buffer, 1.5 μL dNTP, 1.5 μL P5 primer mix, 10 μM, 1.5 μL of P7 primer 10 μM, 2.5 μl DMSO, 0.5 μL polymerase, up to 2 μg of genomic DNA or 10 ng of plasmid DNA, up to 50 μL with water. PCR cycling conditions were as per manufactures protocol. Target PCR products were gel extracted using the Qiagen gel extraction kit and re-purified with the GeneJET PCR Purification kit (Thermo) before sequencing on an Illumina NextSeq500. Fastq files were mapped to the sgRNA library Index using MAGeCK-VISPR v0.5.6, which allows for automated trimming of adaptors and identification of sgRNA length24. Ranked sgRNA and gene hits were similarly obtained with the MAGeCK-VISPR workflow using Robust Rank Aggregation.
GO term enrichment
GO term enrichment was carried out in R using the enrichGO function of clusterProfiler v4.12.249. Enriched BP, CC, or MF were filtered based on an adjusted p value of <0.05. In some cases, top enriched terms were visualized by tree plots of related GO clusters
Seahorse flux analyses
Extracellular flux analyses to measure OCRs and ECARs were performed using the Seahorse-8 XFp flux analyzer (Agilent). BMDMhs were plated at a density of 1 × 105 cells/well in eight-well Seahorse plates overnight. Cells were then infected with Mtb Erdman strain at MOI 1 or left uninfected for another 24 hours. 1 hour before the assay, BMDMh media was replaced with Seahorse base medium (without phenol red and sodium bicarbonate, with 5 mM HEPES) and placed at 37 °C in a non-CO2 incubator. For the Mito stress test to measure OCR, 10 mM glucose, 2 mM L-glutamine, and 1 mM sodium pyruvate were added to the Seahorse base medium, while only glutamine was added for the Glycolysis stress test to measure ECARs. OCR and ECAR measurements (normalized to the number of seeded cells per well) were performed in line with specific kit instructions by sequential injection of oligomycin (2.5 μM), FCCP, fluoro-carbonyl cyanide phenylhydrazone (1.5 μM), rotenone/antimycin A (0.5 μM) for the Mito stress assay and glucose (10 mM), oligomycin (2.5 μM), 2-Deoxy-D-glucose (50 mM) for the Glycolysis stress assay. Three measurements were taken under basal conditions and after each drug injection.
Western blot analysis
Cells were washed in ice-cold 1× PBS and lysed with RIPA buffer (Thermo Fisher) containing protease inhibitors (Roche) for 30 minutes at 4 °C with gentle agitation. The Pierce™ Rapid Gold BCA Protein Assay Kit (Thermo Fisher) was used to measure the concentration of protein lysates. Equal amounts of protein (30 μg) were separated by SDS PAGE on a 4–20% gradient gel and transferred to a nitrocellulose membrane. The membrane was blocked for non-specific binding by incubating with 5% non-fat milk in PBST (0.1% tween in 1× PBS) for at least 30 minutes. Blots were washed and incubated with primary antibodies diluted in 2% non-fat milk in PBST at 4 °C overnight. The following primary antibodies were used in western blot analyses. Anti-AMPKα Mab (1:1000, Cell signaling Technology), anti-Phospho-AMPKα Mab (1:500, Cell signaling Technology), anti-β Actin (1:1000, Cell Signaling Technology), anti-LC3B (1:1000, Cell Signaling Technology), anti-GID8 (1:1000, Proteintech), anti-YPEL5 (1:1000, Proteintech), anti-WDR26 (1:300, Bioss), anti-UBE2H (1:1000, Proteintech), anti-MAEA (1 μg/ml, R&D Systems), anti-MKLN1 (1:250, Proteintech), anti-RANBP9 (1:1000, Proteintech) anti-IL-1β (1:1000, Cell Signaling Technology). Secondary antibodies used were horseradish peroxidase-conjugated polyclonal donkey anti-sheep IgG (1:1000, R&D Systems) and anti-rabbit/mouse StarBright Blue 700 (1:2500, Biorad). Blots were developed by the SuperSignal™ West Atto Ultimate Sensitivity Substrate (Thermo Fisher) or directly imaged in case of fluorescent secondary antibodies. Images were acquired on a ChemiDoc MP imaging system (Biorad). Western blot band intensities were quantified in ImageJ.
Dual RNA-sequencing of BMDMh Mtb infected macrophages
Dual RNA-sequencing of Mtb infected BMDMhs was carried out as described previously47,85 with modifications as described below. Briefly, BMDMhs were infected with the Mtb Erdman smyc’::mCherry reporter strain at MOI 0.5. Four days post infection, cells were harvested and stained with the live/dead viability dye eFlour 506 (Invitrogen; 1:1000) and the PE anti-mouse/human CD11b antibody (Biolegend; 1:500) for 30 minutes at 4 °C. Live mCherry Cd11b positive cells were sorted on a Sony MA900 sorter. 250,000 Mtb infected sorted macrophages were spun down, resuspended in 150 μl sorter buffer, and transferred to a tube containing 600 μl Trizol. Samples were mixed and incubated at room temperature for 5 minutes followed by centrifugation at ~12,000 × g for 20 minutes to pellet the bacteria. 600 μl of Trizol supernatant (host RNA) was then transferred to a new tube. Fresh 400 μl of Trizol was added to the tube containing the bacterial pellet together with 150 μl of zirconia beads. Bead beating was performed on a FastPrep-24™ bead beater (MP biomedicals) in 2 cycles of 1 minute, resting 2 minutes on ice between each cycle. 40% of host RNA (~240 μl) was then added back to the original bead-containing tube, which allows for a good proportion capture of both host and bacteria transcripts by getting rid of some of the host RNA47,85. Chloroform was added (200 µL of chloroform for 1 mL of Trizol) to the tubes which were mixed thoroughly and spun at 12,000 × g for 15 minutes at 4 °C. Total RNA was purified from the aqueous phase using the Zymo RNA clean and concentrator-5 kit according to manufactures instructions. Ribosomal RNA (rRNA) depletion in the RNA samples was performed using the QIAseq FastSelect pan-bacterial and H/M/R kits in the duo-depletion mode. Libraries were prepared from rRNA-depleted samples using the NEBNext Ultra II Directional RNA Library Prep Kit (New England Biolabs) and sequenced on the Novaseq 6000 S4 (Illumina). Paired-end sequenced reads were mapped to the mouse reference genome (GRCm39) and the Mtb H37Rv genome (ASM19595v2) using STAR-2.7.10b. Raw counts were obtained using HTSeq v2.02 with GRCm39 and ASM19595v2 annotations. Normalization of read counts and differential expression analysis were performed in R using DESeq2 v1.44.0 and APEGLM v1.26.1 for log fold change estimation as described previously47,85. Genes with <10 raw counts were excluded from downstream analyzes. Pathway enrichment was performed on DE genes using clusterProfiler as described in the prior section.
Intracellular Ca2+ mobilization assay
BMDMhs were seeded in 96-well black clear bottom plates at a density of 1 × 105 cells/well and incubated at 37 °C in 5% CO2 overnight. The next day, macrophage media was discarded and replaced with the Fluoforte® dye (Enzo Life) in 100 μl Hank’s balanced salt solution (HBSS) in the presence of a dye efflux inhibitor. After 1 hour of incubation (45 minutes at 37 °C and 15 minutes at room temperature), 20 μl of 6 μM ATP was added to each well for a final concentration of 1 μM. Fluoforte® fluorescence (excitation 490 nM/emission 525 nM) was quantified at time 0 (baseline) and after 5 minutes on an Envision plate reader (PerkinElmer). Normalized relative fluorescence units (ΔRFU) were calculated for each well using the following formula:
ΔRFU = (Fluorescence taken after 5 minutes of ATP stimulation−Baseline fluorescence taken at the start of the assay)/Baseline fluorescence taken at the start of the assay.
Immunofluorescence and confocal microscopy
Macrophage monolayers in Ibidi eight-well chambers were infected with Mtb at an appropriate MOI as described in prior sections. At specified time intervals, cells were fixed with 4% PFA for >1 hour and permeabilized with 0.2% Triton X-100 (Sigma-Aldrich) for 15 minutes. Permeabilized cells were blocked with 3% bovine serum albumin (BSA) for 1 hour and incubated with primary antibody diluted in 3% BSA at 4 °C overnight. Next day, cells were washed with 1× PBS three times and incubated with secondary antibodies for 1 hour at room temperature. Primary antibodies used were anti-GABA (1:400, Sigma-Aldrich) and anti-LC3B (1:1000, Cell Signaling Technology). The Alexa Fluor™ 647 goat anti-rabbit secondary antibody (1:500, Thermo Scientific) was used. After mounting, images were acquired using a Leica SP5 confocal microscope. Z-stacks were re-constructed in ImageJ, from which mean fluorescence intensities (MFI) for individual cells or colocalizations were performed.
CRISPR RNP delivery in human monocyte-derived macrophages
Isolated human monocytes were left in culture for 24 hours before transfection. On the day of transfection, cells were harvested, washed with 1× PBS, and resuspended in P3 Primary Cell Nucleofection Buffer (Lonza) at a concentration of 5 × 106 cells in 20 μl for each electroporation. Equal volumes of 100 μM Alt-R crRNA and Alt-tracrRNA (IDT) were annealed to form sgRNA duplexes by incubation at 95 °C for 5 minutes followed by cooling to room temperature for >15 minutes. To form CRISPR RNPs, annealed sgRNA duplexes were mixed with IDT Alt-R S.p. Cas9 Nuclease V3 at a 3:1 molar ratio and incubated for at least 20 minutes at room temperature. For nucleofection, 4 μl of CRISPR RNP was mixed with the 20 μl cell suspension in P3 buffer and transferred into the supplied nucleofector cassette strip. The strip was inserted into the Lonza 4D-Nucleofector and nucleofected with the Buffer P3, CM-137 conditions as previously described40. After nucleofection, cells were transferred into Petri dishes and allowed to complete differentiation to HMDMs for 5–6 days. Knockout efficiencies were confirmed in HMDMs by ICE analysis and western blot.
Quantitative RT-PCR
Total RNA was isolated from uninfected or Mtb-infected BMDMhs using Trizol alongside the Zymo RNA clean and concentrator-5 kit according to manufactures’ instructions. cDNA was synthesized from ~1 μg of extracted RNA using an iScript cDNA synthesis kit (BioRad). RT-PCR was performed for IFN-β and IL-1β on the Applied Biosystems PRISM 7500 qPCR machine. Beta 2 microglobulin was used as a reference housekeeping gene. Predesigned qPCR primers were purchased from IDT. PCR reactions were carried out using iTaq Universal SYBR Green Supermix (BioRad).
ELISA
BMDMhs in 96-well plates were infected with Mtb at an appropriate MOI for 24 hours. Cell culture supernatants were collected from infected cells and assayed for IFN-β and IL-1β using the IFN-β and IL-1β R&D ELISA kits according to manufactures’ instructions.
General statistics
Basic statistical tests were carried out in GraphPad Prism 10. Comparisons between more than two groups were analyzed using one-way or two ANOVA alongside Dunnett’s multiple comparison test. P values < 0.05 were considered statistically significant.
Reporting summary
Further information on research design is available in the Nature Portfolio Reporting Summary linked to this article.
Data availability
The dual RNA-seq data sets supporting the conclusions of this article are available in GEO: GSE267063. https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE267063. Source data of plotted graphs and uncropped versions of blots are provided as a Source Data file. Source data are provided with this paper.
References
WHO. Global tuberculosis report 2023. World Health Organisation, Geneva, Switzerland (2023).
Behr, M. A., Edelstein, P. H. & Ramakrishnan, L. Rethinking the burden of latent tuberculosis to reprioritize research. Nat. Microbiol. 9, 1157–1158 (2024).
Sturgill-Koszycki, S. et al. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase. Science 263, 678–681 (1994).
Upadhyay, S., Mittal, E. & Philips, J. A. Tuberculosis and the art of macrophage manipulation. Pathog. Dis. 76, fty037 (2018).
Huang, L., Nazarova, E. V. & Russell, D. G. Mycobacterium tuberculosis: Bacterial fitness within the host macrophage. Microbiol. Spectr. 7, 10.1128 (2019).
Russell, D. G. et al. Mycobacterium tuberculosis wears what it eats. Cell Host Microbe 8, 68–76 (2010).
Wilburn, K. M., Fieweger, R. A. & VanderVen, B. C. Cholesterol and fatty acids grease the wheels of Mycobacterium tuberculosis pathogenesis. Pathog. Dis. 76, fty021 (2018).
Guilliams, M. et al. Alveolar macrophages develop from fetal monocytes that differentiate into long-lived cells in the first week of life via GM-CSF. J. Exp. Med. 210, 1977–1992 (2013).
Guilliams, M. & Scott, C. L. Does niche competition determine the origin of tissue-resident macrophages? Nat. Rev. Immunol. 17, 451–460 (2017).
Huang, L., Nazarova, E. V., Tan, S., Liu, Y. & Russell, D. G. Growth of Mycobacterium tuberculosis in vivo segregates with host macrophage metabolism and ontogeny. J. Exp. Med. 215, 1135–1152 (2018).
Behar, S. M. et al. Apoptosis is an innate defense function of macrophages against Mycobacterium tuberculosis. Mucosal Immunol. 4, 279–287 (2011).
Martin, C. J. et al. Efferocytosis is an innate antibacterial mechanism. Cell Host Microbe 12, 289–300 (2012).
Sun, J. et al. The tuberculosis necrotizing toxin kills macrophages by hydrolyzing NAD. Nat. Struct. Mol. Biol. 22, 672–678 (2015).
Chen, M., Gan, H. & Remold, H. G. A mechanism of virulence: virulent Mycobacterium tuberculosis strain H37Rv, but not attenuated H37Ra, causes significant mitochondrial inner membrane disruption in macrophages leading to necrosis. J. Immunol. 176, 3707–3716 (2006).
van der Wel, N. et al. M. tuberculosis and M. leprae translocate from the phagolysosome to the cytosol in myeloid cells. Cell 129, 1287–1298 (2007).
Simeone, R. et al. Phagosomal rupture by Mycobacterium tuberculosis results in toxicity and host cell death. PLoS Pathog. 8, e1002507 (2012).
Romagnoli, A. et al. ESX-1 dependent impairment of autophagic flux by Mycobacterium tuberculosis in human dendritic cells. Autophagy 8, 1357–1370 (2012).
Shah, S. et al. Cutting edge: Mycobacterium tuberculosis but not nonvirulent Mycobacteria inhibits IFN-β and AIM2 inflammasome-dependent IL-1β production via its ESX-1 secretion system. J. Immunol. 191, 3514–3518 (2013).
Zhang, L., Jiang, X., Pfau, D., Ling, Y. & Nathan, C. F. Type I interferon signaling mediates Mycobacterium tuberculosis-induced macrophage death. J. Exp. Med. 218, e20200887 (2021).
Lai, Y. et al. Illuminating host-mycobacterial interactions with genome-wide CRISPR knockout and CRISPRi screens. Cell Syst. 11, 239–251.e237 (2020).
Mahamed, D. et al. Intracellular growth of Mycobacterium tuberculosis after macrophage cell death leads to serial killing of host cells. Elife 6, e22028 (2017).
Kiritsy, M. C. et al. Mitochondrial respiration contributes to the interferon gamma response in antigen-presenting cells. Elife 10, e65109 (2021).
Doench, J. G. et al. Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9. Nat. Biotechnol. 34, 184–191 (2016).
Wang, B. et al. Integrative analysis of pooled CRISPR genetic screens using MAGeCKFlute. Nat. Protoc. 14, 756–780 (2019).
Singh, P. & Subbian, S. Harnessing the mTOR pathway for tuberculosis treatment. Front. Microbiol. 9, 70 (2018).
Kim, J. & Guan, K.-L. mTOR as a central hub of nutrient signalling and cell growth. Nat. Cell Biol. 21, 63–71 (2019).
Gutierrez, M. G. et al. Autophagy is a defense mechanism inhibiting BCG and Mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753–766 (2004).
Singhal, A. et al. Metformin as adjunct antituberculosis therapy. Sci. Transl. Med. 6, 263ra159 (2014).
Theriault, M. E. et al. Iron limitation in M. tuberculosis has broad impact on central carbon metabolism. Commun. Biol. 5, 685 (2022).
Lampert, F. et al. The multi-subunit GID/CTLH E3 ubiquitin ligase promotes cell proliferation and targets the transcription factor Hbp1 for degradation. eLife 7, e35528 (2018).
Kobayashi, N. et al. RanBPM, Muskelin, p48EMLP, p44CTLH, and the armadillo-repeat proteins ARMC8alpha and ARMC8beta are components of the CTLH complex. Gene 396, 236–247 (2007).
Santt, O. et al. The yeast GID complex, a novel ubiquitin ligase (E3) involved in the regulation of carbohydrate metabolism. Mol. Biol. Cell 19, 3323–3333 (2008).
Chen, S. J., Wu, X., Wadas, B., Oh, J. H. & Varshavsky, A. An N-end rule pathway that recognizes proline and destroys gluconeogenic enzymes. Science 355, eaal3655 (2017).
Maitland, M. E. R., Lajoie, G. A., Shaw, G. S. & Schild-Poulter, C. Structural and functional insights into GID/CTLH E3 ligase complexes. Int. J. Mol. Sci. 23, 5863 (2022).
Wang, L. et al. The Ran-binding protein RanBPM can depress the NF-κB pathway by interacting with TRAF6. Mol. Cell Biochem. 359, 83–94 (2012).
Subramanian, M. et al. An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo. J. Clin. Invest. 124, 1296–1308 (2014).
Conant, D. et al. Inference of CRISPR edits from Sanger trace data. CRISPR J. 5, 123–130 (2022).
Wu, J. et al. High-throughput assay to phenotype Salmonella enterica Typhimurium association, invasion, and replication in macrophages. J. Vis. Exp. e51759 (2014).
Eade, C. R. et al. Salmonella pathogenicity Island 1 Is expressed in the chicken intestine and promotes bacterial proliferation. Infect. Immun. 87, e00503–e00518 (2019).
Freund, E. C. et al. Efficient gene knockout in primary human and murine myeloid cells by non-viral delivery of CRISPR-Cas9. J. Exp. Med. 217, e20191692 (2020).
Maitland, M. E. R., Kuljanin, M., Wang, X., Lajoie, G. A. & Schild-Poulter, C. Proteomic analysis of ubiquitination substrates reveals a CTLH E3 ligase complex-dependent regulation of glycolysis. FASEB J. 35, e21825 (2021).
Liu, H. et al. The GID ubiquitin ligase complex is a regulator of AMPK activity and organismal lifespan. Autophagy 16, 1618–1634 (2020).
Shi, L., Jiang, Q., Bushkin, Y., Subbian, S. & Tyagi, S. Biphasic dynamics of macrophage immunometabolism during Mycobacterium tuberculosis infection. mBio 10, e02550–18 (2019).
Gleeson, L. E. et al. Cutting edge: Mycobacterium tuberculosis induces aerobic glycolysis in human alveolar macrophages that is required for control of intracellular bacillary replication. J. Immunol. 196, 2444–2449 (2016).
Cumming, B. M., Addicott, K. W., Adamson, J. H. & Steyn, A. J. Mycobacterium tuberculosis induces decelerated bioenergetic metabolism in human macrophages. Elife 7, e39169 (2018).
Garcia, D. & Shaw, R. J. AMPK: mechanisms of cellular energy sensing and restoration of metabolic balance. Mol. Cell 66, 789–800 (2017).
Pisu, D., Huang, L., Grenier, J. K. & Russell, D. G. Dual RNA-seq of Mtb-infected macrophages in vivo reveals ontologically distinct host-pathogen interactions. Cell Rep. 30, 335–350.e334 (2020).
Donovan, A. et al. The iron exporter ferroportin/Slc40a1 is essential for iron homeostasis. Cell Metab. 1, 191–200 (2005).
Wu, T. et al. clusterProfiler 4.0: a universal enrichment tool for interpreting omics data. Innovation 2, 100141 (2021).
Malik, Z. A., Denning, G. M. & Kusner, D. J. Inhibition of Ca(2+) signaling by Mycobacterium tuberculosis is associated with reduced phagosome-lysosome fusion and increased survival within human macrophages. J. Exp. Med. 191, 287–302 (2000).
Stanley, S. A. et al. Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth. PLoS Pathog. 10, e1003946 (2014).
Heisler, F. F. et al. Muskelin regulates actin filament- and microtubule-based GABA(A) receptor transport in neurons. Neuron 70, 66–81 (2011).
Kim, J. K. et al. GABAergic signaling linked to autophagy enhances host protection against intracellular bacterial infections. Nat. Commun. 9, 4184 (2018).
Krithika, R. et al. A genetic locus required for iron acquisition in Mycobacterium tuberculosis. Proc. Natl Acad. Sci. USA 103, 2069–2074 (2006).
Pandey, S. D. et al. Iron-regulated protein HupB of Mycobacterium tuberculosis positively regulates siderophore biosynthesis and is essential for growth in macrophages. J. Bacteriol. 196, 1853–1865 (2014).
Wipperman, M. F., Yang, M., Thomas, S. T. & Sampson, N. S. Shrinking the FadE proteome of Mycobacterium tuberculosis: insights into cholesterol metabolism through identification of an α2β2 heterotetrameric acyl coenzyme A dehydrogenase family. J. Bacteriol. 195, 4331–4341 (2013).
Lack, N. A. et al. Characterization of a carbon-carbon hydrolase from Mycobacterium tuberculosis involved in cholesterol metabolism. J. Biol. Chem. 285, 434–443 (2010).
Forrellad, M. A. et al. Role of the Mce1 transporter in the lipid homeostasis of Mycobacterium tuberculosis. Tuberculosis 94, 170–177 (2014).
Nazarova, E. V. et al. Rv3723/LucA coordinates fatty acid and cholesterol uptake in Mycobacterium tuberculosis. Elife 6, e26969 (2017).
Lott, J. S. The tryptophan biosynthetic pathway is essential for Mycobacterium tuberculosis to cause disease. Biochem. Soc. Trans. 48, 2029–2037 (2020).
Zhang, Y. J. et al. Tryptophan biosynthesis protects Mycobacteria from CD4 T-cell-mediated killing. Cell 155, 1296–1308 (2013).
Tews, I. et al. The structure of a pH-sensing Mycobacterial adenylyl cyclase holoenzyme. Science 308, 1020–1023 (2005).
Bush, M. J. The actinobacterial WhiB-like (Wbl) family of transcription factors. Mol. Microbiol. 110, 663–676 (2018).
Chen, Z. et al. Mycobacterial WhiB6 differentially regulates ESX-1 and the Dos regulon to modulate granuloma formation and virulence in Zebrafish. Cell Rep. 16, 2512–2524 (2016).
Bosserman, R. E. et al. WhiB6 regulation of ESX-1 gene expression is controlled by a negative feedback loop in Mycobacterium marinum. Proc. Natl. Acad. Sci. USA 114, E10772–e10781 (2017).
Kudhair, B. K. et al. Structure of a Wbl protein and implications for NO sensing by M. tuberculosis. Nat. Commun. 8, 2280 (2017).
Khan, S. et al. Toxin-Antitoxin system of Mycobacterium tuberculosis: roles beyond stress sensor and growth regulator. Tuberculosis (Edinb.) 143, 102395 (2023).
Levi, G. & Raiteri, M. Modulation of gamma-aminobutyric acid transport in nerve endings: role of extracellular gamma-aminobutyric acid and of cationic fluxes. Proc. Natl Acad. Sci. USA 75, 2981–2985 (1978).
Weidberg, H. et al. LC3 and GATE-16/GABARAP subfamilies are both essential yet act differently in autophagosome biogenesis. EMBO J. 29, 1792–1802 (2010).
Wei, Q. et al. MAEA is an E3 ubiquitin ligase promoting autophagy and maintenance of haematopoietic stem cells. Nat. Commun. 12, 2522 (2021).
Atabakhsh, E., Bryce, D. M., Lefebvre, K. J. & Schild-Poulter, C. RanBPM has proapoptotic activities that regulate cell death pathways in response to DNA damage. Mol. Cancer Res. 7, 1962–1972 (2009).
Liu, T., Roh, S. E., Woo, J. A., Ryu, H. & Kang, D. E. Cooperative role of RanBP9 and P73 in mitochondria-mediated apoptosis. Cell Death Dis. 4, e476 (2013).
Hawn, T. R., Matheson, A. I., Maley, S. N. & Vandal, O. Host-directed therapeutics for tuberculosis: can we harness the host? Microbiol. Mol. Biol. Rev. 77, 608–627 (2013).
Young, C., Walzl, G. & Du Plessis, N. Therapeutic host-directed strategies to improve outcome in tuberculosis. Mucosal Immunol. 13, 190–204 (2020).
Ye, Y., Tang, X., Sun, Z. & Chen, S. Upregulated WDR26 serves as a scaffold to coordinate PI3K/ AKT pathway-driven breast cancer cell growth, migration, and invasion. Oncotarget 7, 17854–17869 (2016).
Huffman, N., Palmieri, D. & Coppola, V. The CTLH complex in cancer cell plasticity. J. Oncol. 2019, 4216750 (2019).
Jiang, G. et al. A novel biomarker ARMc8 promotes the malignant progression of ovarian cancer. Hum. Pathol. 46, 1471–1479 (2015).
Dartois, V. A. & Rubin, E. J. Anti-tuberculosis treatment strategies and drug development: challenges and priorities. Nat. Rev. Microbiol. 20, 685–701 (2022).
Sukumar, N., Tan, S., Aldridge, B. B. & Russell, D. G. Exploitation of Mycobacterium tuberculosis reporter strains to probe the impact of vaccination at sites of infection. PLoS Pathog. 10, e1004394 (2014).
Dhandayuthapani, S. et al. Green fluorescent protein as a marker for gene expression and cell biology of Mycobacterial interactions with macrophages. Mol. Microbiol. 17, 901–912 (1995).
Andreu, N. et al. Optimisation of bioluminescent reporters for use with Mycobacteria. PLoS One 5, e10777 (2010).
Nazarova, E. V. & Russell, D. G. Growing and handling of Mycobacterium tuberculosis for macrophage infection assays. Methods Mol. Biol. 1519, 325–331 (2017).
Hart, T. et al. Evaluation and design of genome-wide CRISPR/SpCas9 knockout screens. G3 (Bethesda) 7, 2719–2727 (2017).
Chen, S. et al. Genome-wide CRISPR screen in a mouse model of tumor growth and metastasis. Cell 160, 1246–1260 (2015).
Pisu, D., Huang, L., Rin Lee, B. N., Grenier, J. K. & Russell, D. G. Dual RNA-sequencing of Mycobacterium tuberculosis-infected cells from a murine infection model. STAR Protoc. 1, 100123 (2020).
Acknowledgements
We thank Dr. Jen K. Grenier and Ann E. Tate from the Cornell BRC Transcriptional Regulation and Expression Facility for on-going support to improve the Dual RNA-sequencing protocols. Some graphics in Figs. 1C and S1B were obtained from Biorender.com. This work was supported by grants from the National Institutes of Health (AI155319, AI162598, and OD032135), Bill and Melinda Gates Foundation, and the Mueller Health Foundation to D.G.R., and by a grant from the National Institutes of Health (AI172433) to C.A. E.J. was supported by T32AI007349.
Author information
Authors and Affiliations
Contributions
N.V.S. and D.G.R. conceptualized the study. L.J., P.P.B., and E.J. contributed to the acquisition and analysis of data. C.A. and C.M.S. contributed to data interpretation. D.G.R. acquired funding for the study. N.V.S. and D.G.R. wrote the original draft. N.V.S., D.G.R., L.J., P.P.B., E.J., C.A., and C.M.S. reviewed and edited the manuscript.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Peer review
Peer review information
Nature Communications thanks Vincenzo Coppola, Laura Jenniches and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. A peer review file is available.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Source data
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Simwela, N.V., Johnston, L., Bitar, P.P. et al. Genome-wide screen of Mycobacterium tuberculosis-infected macrophages revealed GID/CTLH complex-mediated modulation of bacterial growth. Nat Commun 15, 9322 (2024). https://doi.org/10.1038/s41467-024-53637-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41467-024-53637-z
This article is cited by
-
How macrophage heterogeneity affects tuberculosis disease and therapy
Nature Reviews Immunology (2025)
-
Muskelin is a substrate adaptor of the highly regulated Drosophila embryonic CTLH E3 ligase
EMBO Reports (2025)